A beneficial role for regulatory B cells has also been described in humans for the two autoimmune diseases where reduced CD40 increases susceptibility, namely multiple sclerosis and inflammatory bowel disease (Li et al., 2015, Dooley et al., 2016). This evidence concerns the gene CD40 and autoimmune disease.